Annual CFO
-$81.64 M
-$22.80 M-38.74%
31 December 2023
Summary:
Kezar Life Sciences annual cash flow from operations is currently -$81.64 million, with the most recent change of -$22.80 million (-38.74%) on 31 December 2023. During the last 3 years, it has fallen by -$44.70 million (-120.97%). KZR annual CFO is now -906.84% below its all-time high of -$8.11 million, reached on 31 December 2017.KZR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$17.49 M
-$463.00 K-2.72%
30 September 2024
Summary:
Kezar Life Sciences quarterly cash flow from operations is currently -$17.49 million, with the most recent change of -$463.00 thousand (-2.72%) on 30 September 2024. Over the past year, it has increased by +$2.71 million (+13.42%). KZR quarterly CFO is now -982.55% below its all-time high of -$1.62 million, reached on 31 December 2017.KZR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$76.37 M
+$2.71 M+3.43%
30 September 2024
Summary:
Kezar Life Sciences TTM cash flow from operations is currently -$76.37 million, with the most recent change of +$2.71 million (+3.43%) on 30 September 2024. Over the past year, it has increased by +$2.18 million (+2.78%). KZR TTM CFO is now -3695.58% below its all-time high of -$2.01 million, reached on 31 March 2017.KZR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KZR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.7% | +13.4% | +2.8% |
| 3 y3 years | -121.0% | -75.8% | -87.8% |
| 5 y5 years | -292.7% | -111.9% | -171.4% |
KZR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -121.0% | at low | -75.8% | +23.5% | -87.8% | +8.7% |
| 5 y | 5 years | -292.7% | at low | -142.6% | +23.5% | -171.4% | +8.7% |
| alltime | all time | -906.8% | at low | -982.5% | +23.5% | -3695.6% | +8.7% |
Kezar Life Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.49 M(+2.7%) | -$76.37 M(-3.4%) |
| June 2024 | - | -$17.03 M(-25.5%) | -$79.08 M(-5.5%) |
| Mar 2024 | - | -$22.86 M(+20.5%) | -$83.65 M(+2.5%) |
| Dec 2023 | -$81.64 M(+38.7%) | -$18.98 M(-6.1%) | -$81.64 M(+3.9%) |
| Sept 2023 | - | -$20.20 M(-6.5%) | -$78.55 M(+5.1%) |
| June 2023 | - | -$21.60 M(+3.5%) | -$74.70 M(+12.5%) |
| Mar 2023 | - | -$20.86 M(+31.3%) | -$66.39 M(+12.8%) |
| Dec 2022 | -$58.85 M(+38.7%) | -$15.88 M(-2.9%) | -$58.85 M(+8.9%) |
| Sept 2022 | - | -$16.36 M(+23.1%) | -$54.04 M(+13.4%) |
| June 2022 | - | -$13.29 M(-0.2%) | -$47.64 M(+0.5%) |
| Mar 2022 | - | -$13.31 M(+20.2%) | -$47.39 M(+11.7%) |
| Dec 2021 | -$42.44 M(+14.9%) | -$11.08 M(+11.3%) | -$42.44 M(+4.4%) |
| Sept 2021 | - | -$9.95 M(-23.7%) | -$40.66 M(+1.8%) |
| June 2021 | - | -$13.04 M(+56.1%) | -$39.96 M(+8.0%) |
| Mar 2021 | - | -$8.36 M(-10.2%) | -$37.01 M(+0.2%) |
| Dec 2020 | -$36.95 M | -$9.31 M(+0.6%) | -$36.95 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$9.25 M(-8.3%) | -$34.85 M(+2.9%) |
| June 2020 | - | -$10.09 M(+21.6%) | -$33.86 M(+7.6%) |
| Mar 2020 | - | -$8.30 M(+15.1%) | -$31.48 M(+5.4%) |
| Dec 2019 | -$29.88 M(+43.7%) | -$7.21 M(-12.7%) | -$29.88 M(+6.2%) |
| Sept 2019 | - | -$8.26 M(+7.0%) | -$28.14 M(+14.9%) |
| June 2019 | - | -$7.71 M(+15.1%) | -$24.49 M(+3.2%) |
| Mar 2019 | - | -$6.70 M(+22.4%) | -$23.73 M(+14.1%) |
| Dec 2018 | -$20.79 M(+156.4%) | -$5.47 M(+18.9%) | -$20.79 M(+22.8%) |
| Sept 2018 | - | -$4.60 M(-33.7%) | -$16.93 M(+16.7%) |
| June 2018 | - | -$6.95 M(+84.5%) | -$14.51 M(+47.1%) |
| Mar 2018 | - | -$3.77 M(+133.0%) | -$9.86 M(+21.6%) |
| Dec 2017 | -$8.11 M(-16.9%) | -$1.62 M(-25.8%) | -$8.11 M(+24.9%) |
| Sept 2017 | - | -$2.18 M(-5.4%) | -$6.49 M(+50.5%) |
| June 2017 | - | -$2.30 M(+14.5%) | -$4.32 M(+114.5%) |
| Mar 2017 | - | -$2.01 M | -$2.01 M |
| Dec 2016 | -$9.76 M | - | - |
FAQ
- What is Kezar Life Sciences annual cash flow from operations?
- What is the all time high annual CFO for Kezar Life Sciences?
- What is Kezar Life Sciences annual CFO year-on-year change?
- What is Kezar Life Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kezar Life Sciences?
- What is Kezar Life Sciences quarterly CFO year-on-year change?
- What is Kezar Life Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Kezar Life Sciences?
- What is Kezar Life Sciences TTM CFO year-on-year change?
What is Kezar Life Sciences annual cash flow from operations?
The current annual CFO of KZR is -$81.64 M
What is the all time high annual CFO for Kezar Life Sciences?
Kezar Life Sciences all-time high annual cash flow from operations is -$8.11 M
What is Kezar Life Sciences annual CFO year-on-year change?
Over the past year, KZR annual cash flow from operations has changed by -$22.80 M (-38.74%)
What is Kezar Life Sciences quarterly cash flow from operations?
The current quarterly CFO of KZR is -$17.49 M
What is the all time high quarterly CFO for Kezar Life Sciences?
Kezar Life Sciences all-time high quarterly cash flow from operations is -$1.62 M
What is Kezar Life Sciences quarterly CFO year-on-year change?
Over the past year, KZR quarterly cash flow from operations has changed by +$2.71 M (+13.42%)
What is Kezar Life Sciences TTM cash flow from operations?
The current TTM CFO of KZR is -$76.37 M
What is the all time high TTM CFO for Kezar Life Sciences?
Kezar Life Sciences all-time high TTM cash flow from operations is -$2.01 M
What is Kezar Life Sciences TTM CFO year-on-year change?
Over the past year, KZR TTM cash flow from operations has changed by +$2.18 M (+2.78%)